Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

19.13
+0.58003.13%
Pre-market: 20.251.12+5.85%08:53 EDT
Volume:864.43K
Turnover:16.74M
Market Cap:2.10B
PE:-7.47
High:19.98
Open:18.40
Low:17.77
Close:18.55
Loading ...
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 22, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2023

Correspondence

Form CORRESP - Correspondence
Sep 20, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Aug 15, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 01, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]